Rayonier Inc.
RYN
position
long
H. Kevin Byun
Thesis
Rayonier's upcoming spin-off of its specialty chemical business is expected to unlock significant value, with the spin-off potentially valued at $25 to $35 per share. The parent company is also expected to have a strong dividend yield, making it an attractive investment.
Did it work?
failed
confidence: high
The thesis anticipated a significant value unlock from the spin-off, with a projected valuation of $25 to $35 per share. However, the stock has declined by 51.1%, indicating that the anticipated value creation did not materialize, and the investment thesis has failed to hold up.
Raw excerpt
No raw excerpt stored.